The Candida albicans phosphomannan complex in Candida-host interactions

Research in Immunology

Volumn 149, Issue 4-5, 1998, Pages 299-308

  Cutler, J E ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

CANDIDA ALBICANS; CANDIDIASIS; CELL SURFACE; CELL WALL; GENE CONTROL; HYDROLYSIS; IMMUNE RESPONSE; PRIORITY JOURNAL; REVIEW; VIRULENCE;

EID: 0032077836     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(98)80754-2     Document Type: Article

References (79)

1. Bailey, D.A., Feldmann, P.J.F., Bovey, M., Gow, N.A.R. & Brown, A.J.P. (1996), The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins. J. Bacteriol., 178, 5353-5360.
2. Barturen, B., Bikandi, J., San Millan, R., Moragues, M.D., Regulez, P., Quindos, G. & Ponton, J. (1995), Variability in expression of antigens responsible for serotype specificity in Candida albicans. Microbiology, 141, 1535-1543.
3. Braun, B.R. & Johnson, A.D. (1997), Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science, 277, 105-109.
4. Brawner, D.L. (1991), Comparison between methods for serotyping of Candida albicans produces discrepancies in results. J. Clin. Microbiol., 29, 1020-1025.
5. Brawner, D.L. & Cutler, J.E. (1984), Variability in expression of a cell surface determinant on Candida albicans as evidenced by an agglutinating monoclonal antibody. Infect. Immun., 43, 966-972.
6. Brawner, D.L. & Cutler, J.E. (1986), Variability in expression of cell surface antigens of Candida albicans during morphogenesis. Infect. Immun., 51, 337-343.
7. Brawner, D.L. & Cutler, J.E. (1987), Cell surface and intracellular expression of two Candida albicans antigens during in vitro and in vivo growth. Microbiol. Pathogen., 2, 249-257.
8. Butcher, E.C., Scollay, R.G. & Weissman, I.L. (1979), Lymphocyte adherence to high endothelial venules: characterization of a modified in vitro assay, and examination of the binding of syngeneic and allogeneic lymphocyte populations. J. Immunol., 123, 1996-2003.
9. Caesar-TonThat, T.-C. & Cutler, J.E. (1997), A monoclonal antibody to Candida albicans enhances mouse neutrophil candidacidal activity. Infect. Immun., 65, 5354-5357.
10. Chen, J.-Y. & Fonzi, W.A. (1992), A temperature-regulated, retrotransposon-like element from Candida albicans. J. Bacteriol., 174, 5624-5632.
11. Cox, R.A. (1993), Coccidioidomycosis, in "Infectious agents and pathogenesis: fungal infections and immune responses" (J.W. Murphy, H. Friedman, and M. Bendinelli) (pp. 173-212). Plenum Press, New York.
12. Csank, C., Makris, C., Meloche, S., Schroppel, K., Rollinghoff, M., Dignard, D., Thomas, D.Y. & Whiteway, M. (1997), Derepressed hyphal growth and reduced virulence in a VH1 family-related protein phosphatase mutant of the human pathogen Candida albicans. Mol. Biol. Cell, 8, 2539-2551.
13. Cutler, J.E. (1991), Putative virulence factors of Candida albicans. Ann. Rev. Microbiol., 45, 187-218.
14. Cutler, J.E., Brawner, D.L., Hazen, K.C. & Jutila, M.A. (1990), Characteristics of Candida albicans adherence to mouse tissue. Infect. Immun., 58, 1902-1908.
15. Cutler, J.E. & Kanbe, T. (1994), Antigenic variability of Candida albicans, in "Curr. Top. Med. Mycol." (M. Borgers, R. Hay, and M.G. Rinaldi). Prous Sci. Pub.
16. Deslauriers, N., Michaud, J., Carre, B. & Leveillee, C. (1996), Dynamic expression of cell-surface antigens probed with Candida albicans specific monoclonal antibodies. Microbiology, 142, 1239-1248.
17. Domer, J.E. & Lehrer, R.I. (1993), Introduction to Candida: Systemic candidiasis, in "Infectious agents and pathogenesis; Fungal infections and immune responses" (J.W. Murphy, H. Friedman, and M. Bendinelli) (pp. 49-116). Plenum Press, New York.
18. Eisman, P.C., Geftic, S.G. & Mayer, R.L. (1953), Virulence in mice of colonial variants of Candida albicans. Proc. Soc. Exp. Biol. Med., 82, 263-264.
19. Fradin, C., Jouault, T., Mallet, A., Mallet, J.M., Camus, D., Sinay, P. & Poulain, D. (1996), β-1,2-linked oligomannosides inhibit Candida albicans binding to murine macrophage. J. Leukocyte Biol., 60, 81-87.
20. Fukazawa, Y. & Kagaya, K. (1997), Molecular bases of adhesion of Candida albicans. J. Med. Vet. Mycol., 35, 87-99.
21. George, B.S. & Plunkett, O.A. (1948), Dissociation in Candida albicans. J. Invest. Dermatol., 10, 327-442.
22. Glee, P.M., Sundstrom, P. & Hazen, K.C. (1995), Expression of surface hydrophobic proteins by Candida albicans in vivo. Infect. Immun., 63, 1373-1379.
23. Graser, Y., Volovsek, M., Arrington, J., Schonian, G., Presber, W., Mitchell, T.G. & Vilgalys, R. (1996), Molecular markers reveal that population structure of the human pathogen Candida albicans exhibits both clonality and recombination. Proc. Natl. Acad. Sci. USA 93, 12473-12477.
24. Han, Y., Kanbe, T., Cherniak, R. & Cutler, J.E. (1997), Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies. Infect. Immun., 65, 4100-4107.
25. Han, Y. & Cutler, J.E. (1995), Antibody response that protects against disseminated candidiasis. Infect. Immun., 63, 2714-2719.
26. Han, Y. & Cutler, J.E. (1997), Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J. Infect. Dis., 175, 1169-1175.
27. Hasenclever, H.F., Mitchell, W.O. & Loewe, J. (1961), Antigenic studies of Candida. II. Antigenic relation of Candida albicans group A and group B to Candida stellatoidea and Candida tropicalis. J. Bacteriol., 82, 574-577.
28. Hasenclever, H.F. & Mitchell, W.O. (1961), Antigenic studies of Candida. I. Observation of two antigenic groups in Candida albicans. J. Bacteriol., 82, 570-573.
29. Hazen, B.W. & Hazen, K.C. (1988), Dynamic expression of cell surface hydrophobicity during initial yeast cell growth and before germ tube formation of Candida albicans. Infect. Immun., 56, 2521-2525.
30. Hazen, K.C., Plotkin, B.J. & Klimas, D.M. (1986), Influence of growth conditions on cell surface hydrophobicity of Candida albicans and Candida glabrata. Infect. Immun., 54, 269-271.
31. Hazen, K.C. (1990), Cell surface hydrophobicity of medically important fungi, especially Candida species, in "Microbial Cell Surface Hydrophobicity" (R.J. Doyle and M. Rosenberg) (pp. 249-295). American Society for Microbiology, Washington.
32. Hazen, K.C. & Glee, P.M. (1994), Hydrophobic cell wall protein glycosylation by the pathogenic fungus Candida albicans. Can. J. Microbiol., 40, 266-272.
33. Hazen, K.C. & Glee, P.M. (1996), Cell surface hydrophobicity and medically important fungi. Curr. Top. Med. Mycol., 6, 1-53.
34. Hazen, K.C. & Hazen, B.W. (1992), Hydrophobic surface protein masking by the opportunistic fungal pathogen Candida albicans. Infect. Immun., 60, 1499-1508.
35. Hill, H.R., Kelsey, D.K., Gonzales, L.A. & Raff, H.V. (1992), Monoclonal antibodies in the therapy of experimental neonatal group B streptococcal disease. Clin. Immunol. Immunopathol., 62, 87-91.
36. Hostetter, M.K. (1994), Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces. Clin. Microbiol. Rev., 7, 29-42.
37. Iwaguchi, S.-I., Homma, M. & Tanaka, K. (1990), Variation in the electrophoretic karyotype analysed by the assignment of DNA probes in Candida albicans. J. Gen. Microbiol., 136, 2433-2442.
38. Jouault, T., LePage, G., Bernigaud, A., Trinel, P.-A., Fradin, C., Wieruszeski, J.-M., Strecker, G. & Poulain, D. (1995), β-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production. Infect. Immun., 63, 2378-2381.
39. Kanbe, T., Jutila, M.A. & Cutler, J.E. (1992), Evidence that Candida albicans binds via a unique adhesion system on phagocytic cells in the marginal zone of the mouse spleen. Infect. Immun., 60, 1972-1978.
40. Kanbe, T., Han, Y., Redgrave, B., Riesselman, M.H. & Cutler, J.E. (1993), Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph node tissue. Infect. Immun., 61, 2578-2584.
41. Kanbe, T. & Cutler, J.E. (1994), Evidence for adhesin activity in the acid-stable moiety of the phosphomannoprotein complex of Candida albicans. Infect. Immun., 62, 1662-1668.
42. Klein, B.S. (1997), Role of cell surface molecules of Blastomyces dermatitidis in the pathogenesis and immunobiology of blastomycosis. Semin. Respir. Infect., 12, 198-205.
43. Kobayashi, H., Matsuda, K., Ikeda, T., Suzuki, M., Takahashi, S., Suzuki, A., Shibata, N. & Suzuki, S. (1994), Structures of cell wall mannans of pathogenic Candida tropicalis IFO 0199 and IFO 1647 yeast strains. Infect. Immun., 62, 615-622.
44. Kobayashi, H., Tanaka, S., Suzuki, J., Kiuchi, Y., Shibata, N., Suzuki, S. & Okawa, Y. (1997), Amended structure of side chains in a cell wall mannan from Candida albicans serotype A strain grown in yeast extract-Sabouraud liquid medium under acidic conditions: detection of the branched side chains corresponding to antigenie factor 4. FEMS Microbiol. Lett., 152, 235-242.
45. Kobayashi, S.D. & Cutler, J.E. (1998), Candida albicans hyphal formation and virulence: is there a clearly defined role? Trends Microbiol., 6, 2-4.
46. Kozel, T.R., Weinhold, L. & Lupan, D.M. (1996), Distinct characteristics of initiation of the classical and alternative complement pathway by Candida albicans. Infect. Immun., 64, 3360-3368.
47. Leberer, E., Harcus, D., Broadbent, I.D., Clark, K.L., Dignard, D., Ziegelbauer, K., Schmidt, A., Gow, N.A.R., Brown, A.J.P. & Thomas, D.Y. (1996), Signal transduction through homologs of the Ste20p and Ste7p protein kinases and trigger hyphal formation in the pathogenic fungus Candida albicans. Proc. Natl. Acad. Sci. USA, 93, 13217-13222.
48. Leberer, E., Ziegelbauer, K., Schmidt, A., Harcus, D., Dignard, D., Ash, J., Johnson, L. & Thomas, D.Y. (1997), Virulence and hyphal formation of Candida albicans require the Ste20p-Hke protein kinase CaC1a4p. Curr. Biol., 7, 539-546.
49. Li, R.-K. & Cutler, J.E. (1993), Chemical definition of an epitope/adhesin molecule on Candida albicans. J. Biol. Chem., 268, 18293-18299.
50. Lo, H., Kohler, J.R., DiDomenico, B., Loebenberg, D., Cacciapuoti, A. & Fink, G.R. (1997), Nonfilamentous C. albicans mutants are avirulent. Cell, 90, 939-949.
51. Matthews, G.D., Goodwin, J.D., Butler, M.I., Berryman, T.A. & Poulter, R.T.M. (1997), pCa1, a highly unusual Ty1/copia retrotransposon from the pathogenic yeast Candida albicans. J. Bacteriol., 179, 7118-7128.
52. Miyakawa, Y., Kagaya, K., Fukazawa, Y. & Soe, G. (1986), Production and characterization of agglutinating monoclonal antibodies against predominant antigenic factors for Candida albicans. J. Clin. Microbiol., 23, 881-886.
53. Mourad, S. & Friedman, L. (1961), Active immunization of mice against Candida albicans. Proc. Soc. Exp. Biol. Med., 106, 570-572.
54. Mourad, S. & Friedman, L. (1968), Passive immunization of mice against Candida albicans. South African Med. J., 6, 103-105.
55. Negroni, P. (1935), Variacion hacia el tipo R de Mycotorula albicans. Rev. Soc. Argent. Biol., 11, 449-453.
56. Odds, F.C. (1988a), Morphogenesis in Candida albicans. CRC Crit. Rev. Microbiol., 12, 45-93.
57. Odds, F.C. (1988b), Candida and candidosis. Bailliere Tindall, London.
58. Okawa, Y., Goto, K., Nemoto, S., Akashi, M., Sugawara, C., Hanzawa, M., Kawamata, M., Takashi, T., Shibata, N., Kobayashi, H. & Suzuki, S. (1996), Antigenicity of cell wall mannans of Candida albicans NIH B-792 (serotype B) strain cells cultured at high temperature in yeast extract-containing sabouraud liquid medium. Clin. Diagn. Lab. Immunol., 3, 331-336.
59. Pearsall, N.N., Adams, B.L. & Bunni, R. (1978), Immunologic responses to Candida albicans. III. Effects of passive transfer of lymphoid cells or serum on murine candidiasis. J. Immunol., 120, 1176-1180.
60. Pincus, S.H., Shigeoka, A.O., Moe, A.A., Ewing, L.P. & Hill, H.R. (1988), Protective efficacy of IgM monoclonal antibodies in experimental group B streptococcal infection is a function of antibody. J. Immunol., 140, 2779-2785.
61. Poulain, D., Tronchin, G., Vernes, A., Popeye, R. & Biguet, J. (1983), Antigenic variations of Candida albicans in vivo and in vitro - relationships between P antigens and serotypes. South African Med. J., 21, 99-112.
62. Poulain, D., Hopwood, V. & Vernes, A. (1985), Antigenic variability of Candida albicans. CRC Crit. Rev. Microbiol., 12, 223-270.
63. Qian, Q., Jutila, M.A., van Rooijen, N. & Cutler, J.E. (1994), Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol., 152, 5000-5008.
64. Riesselman, M.H., Kanbe, T. & Cutler, J.E. (1991), Improvements and important considerations of an ex vivo assay to study interactions of Candida albicans with splenic tissue. J. Immunol. Methods, 1450, 153-160.
65. Rustchenko-Bulgac, E.P. (1991), Variations of Candida albicans electrophoretic karyotypes. J. Bacteriol., 173, 6586-6596.
66. Saporito-Irwin, S.M., Birse, C.E., Sypherd, P.S. & Fonzi, W.A. (1995), PHR1, a pH-regulated gene of Candida albicans is required for morphogenesis. Mol. Cell. Biol., 15, 601-613.
67. Scherer, S. & Magee, P.T. (1990), Genetics of Candida albicans. Microbiol. Rev., 54, 226-241.
68. Segal, E. (1996), Inhibitors of Candida albicans adhesion to prevent candidiasis. Adv. Exp. Med. Biol., 197-206.
69. Shibata, N., Arai, M., Haga, E., Kikuchi, T., Najima, M., Satoh, T., Kobayashi, H. & Suzuki, S. (1992), Structural identification of an epitope of antigenic factor 5 in mannans of Candida albicans NIH B-792 (Serotype B) and J-1012 (Serotype A) as Beta-1,2-linked oligomannosyl residues. Infect. Immun., 60, 4100-4110.
70. Shibata, N., Ikuta, K., Imai, T., Satoh, Y., Satoh, R., Suzuki, A., Kojima, C., Kobayashi, H., Hisamichi, K. & Suzuki, S. (1995), Existence of branched side chains in the cell wall mannan of pathogenic yeast, Candida albicans. Structure-antigenicity relationship between the cell wall mannans of Candida albicans and Candida parapsilosis. J. Biol. Chem., 270, 1113-1122.
71. Soll, D.R. (1992), High-frequency switching in Candida albicans. Clin. Microbiol. Rev., 5, 183-203.
72. Stamper, H.B. & Woodruff, J.J. (1976), Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high-endothelial venules. J. Exp. Med., 144, 828-833.
73. Stoldt, V.R., Sonneborn, A., Leuker, C.E. & Ernst, J.F. (1997), Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J., 16, 1982-1991.
74. Suzuki, K., Okawa, Y., Hashimoto, K., Suzuki, S. & Suzuki, M. (1984), Protecting effect of chitin and chitosan on experimentally induced murine candidiasis. Microbiol. Immunol., 28, 903-912.
75. Trinel, P.A., Borg-von-Zepelin, M., LePage, G., Jouault, T., Mackenzie, D. & Poulain, D. (1993), Isolation and preliminary characterization of the 14-to 18-kilodalton Candida albicans antigen as a phospholipomannan containing β-1,2-linked oligomannosides. Infect. Immun., 61, 4398-4405.
76. Trinel, P.A., Cantelli, C., Bernigaud, A., Jouault, T. & Poulain, D. (1996), Evidence for different mannosylation processes involoved in the assocation of β-1,2-linked oligomannosidic epitopes in Candida albicans mannan and phospholipomannan. Microbiology, 142, 2263-2270.
77. Trinel, P.A., LePage, G., Jouault, T., Strecker, G. & Poulain, D. (1997), Definitive chemical evidence for the constitutive ability of Candida albicans serotype A strains to synthesize β-1,2 linked oligomannosides containing up to 14 mannose residues. FEBS Lett., 416, 203-206.
78. Vazquez-Torres, A. & Balish, E. (1997), Macrophages in resistance to candidiasis. Microbiol. Mol. Biol. Rev., 61, 170-192.
79. Yuan, R., Casadevall, A., Spira, G. & Scharff, M.D. (1995), Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J. Immunol., 154, 1810-1816.